Prevalência de talassemias e hemoglobinas variantes em pacientes portadores de lúpus eritematoso sistêmico

Resumo

Systemic lupus erythematosus (SLE) is a typically multigenic and multifatorial disease with remarkable clinical and pathogenic complexities. The causes of SLE are not totally known, but It is known that environmental and genetic factors are involved. Among various clinical manifestations observed in lupus patients, anemia calls the attention because of a prevalence of 52.5% of the patients with RBC indices suggestive of anemia identified in this study. Although anemia is usually seen in patients with SLE, studies of the prevalence of hereditary anemias, particularly hemoglobinopathies, have not been carried out in populations. The objective of this work was to evaluate the prevalence of hemoglobinophaties in patients with SLE. We studied 80 blood samples of patients with SLE in Hospital das Clínicas in Goiania, Brazil. The frequency of alterations of the hemoglobin was 10.0% (8 patients). Among these alterations, the most prevalent was alpha thalassemia in 4 patients (5.0% of the studied population). The heterozygosity for hemoglobin S was seen in 2 patients (2.5%), hemoglobin C in one patient (1.25%) and one patient was identified with beta thalassemia minor. No homozygous cases were found in the present study. According to this work no difference in the prevalence of hemoglobin disorders was observed between general population and patients with SLE. Rev. bras. hematol. hemoter. 2008;30(1):24-28.

Descrição

Palavras-chave

Talassemia, HPLC, Hemoglobinas variantes, Lúpus eritematoso sistêmico, Diagnóstico laboratorial, Thalassemia, Variant hemoglobins, HPLC, Systemic lupus erythematosus, Laboratorial diagnoses

Citação

CASTRO, Frank S. et al.Prevalencia de talassemia e hemoglobinas variantes em pacientes portadores de lupus erimatoso sistemico. Revista Brasileira de Hematologia e Hemoterapia, São José do Rio Preto, v. 30, n. 1, p. 32-37, jan./fev. 2008.